AstraZeneca has confirmed that several of its employees in China are under investigation for potential illegal data collection and unapprov...

Prince Charles will be on hand Tuesday when pharmaceutical company AstraZeneca opens a 1 billion-pound ($1.34 billion) research centre near...

The findings showed although there was an increased risk of having a blood clot after having the first doses of either vaccine, it was much...

The blood clots events have led to restricted use of Covishield in a number of countries.

EU regulators said AstraZeneca hasn't completed the necessary paperwork on the Indian factory, including details on its production practice...

With both the AstraZeneca and Johnson & Johnson (J&J)vaccines, the reports involve extremely rare clotting, including a type of blood clot ...

The EMA said its vaccine side effects monitoring system, as of April 4, had received 169 reports of cases of cerebral venous sinus thrombos...

British Vaccine Deployment Minister Nadhim Zahawi said current COVID-19 vaccines would probably still protect people against infection with...

With efficacy of just over 50% - barely above Brazil's threshold for regulatory approval - the Chinese shot was not the government's first ...

The company has partnered with the Serum Institute of India (SII), the world's largest vaccine manufacturer, for the supply of the vaccine ...

Moderna jumped as much as 17% in New York Tuesday. The stock has surged about 73% and added more than $28 billion in market value over the ...

The Serum Institute of India said it would restart its trials once it had permission from the Drugs Controller General of India, Reuters re...

The drug known as AZD7442 has the potential to be given as a preventative option for people exposed to the coronavirus, and to treat and pr...

Pfizer's potential takeover of AstraZeneca poses a threat to British science unless it can give more concrete, enforceable guarantees on jo...

AstraZeneca said on Tuesday that Pfizer's proposal risked disrupting its research and delaying getting life-saving new drugs to market.

Pfizer Inc.'s chief executive acknowledged Tuesday that a potential merger with AstraZeneca would lead to job losses _ but promised to keep...

Has given a five-year commitment to complete AstraZeneca's new research centre in Cambridge, among other things, if the deal goes ahead.